Patent: 7,968,104
✉ Email this page to a colleague
Summary for Patent: 7,968,104
Title: | Use of neurotoxin therapy for treatment of urologic and related disorders |
Abstract: | The present invention related to methods for treating neurological-urological conditions. This is accomplished by administration of at least one neurotoxin. |
Inventor(s): | Schmidt; Richard A (Arvada, CO) |
Assignee: | Allergan, Inc. (Irvine, CA) |
Application Number: | 12/133,198 |
Patent Claims: | see list of patent claims |
Details for Patent 7,968,104
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Abbvie Inc. | BOTOX COSMETIC | onabotulinumtoxina | For Injection | 103000 | December 09, 1991 | ⤷ Sign Up | 2017-07-15 |
Abbvie Inc. | BOTOX | onabotulinumtoxina | For Injection | 103000 | December 09, 1991 | ⤷ Sign Up | 2017-07-15 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 7,968,104
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 9903483 | ⤷ Sign Up |
United States of America | 9066943 | ⤷ Sign Up |
United States of America | 8840905 | ⤷ Sign Up |
United States of America | 8062643 | ⤷ Sign Up |
United States of America | 8057807 | ⤷ Sign Up |
United States of America | 7470431 | ⤷ Sign Up |
United States of America | 7455845 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |